Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques
Despite the availability of several effective SARS-CoV-2 vaccines, additional vaccines will
be required for optimal global vaccination. In this study, we investigate the immunogenicity …
be required for optimal global vaccination. In this study, we investigate the immunogenicity …
Genome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection
M Sakai, Y Masuda, Y Tarumoto, N Aihara, Y Tsunoda… - Iscience, 2024 - cell.com
Although many host factors important for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection have been reported, the mechanisms by which the virus interacts …
(SARS-CoV-2) infection have been reported, the mechanisms by which the virus interacts …
Genome-scale CRISPR‒Cas9 screen identifies novel host factors as potential therapeutic targets for SARS-CoV-2 infection
M Sakai, Y Masuda, Y Tarumoto, N Aihara, Y Tsunoda… - bioRxiv, 2023 - biorxiv.org
Although many host factors important for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection have been reported, the mechanisms by which the virus interacts …
(SARS-CoV-2) infection have been reported, the mechanisms by which the virus interacts …